| Iu Health Ball Memorial Physicians | |
|
1420 S Pilgrim Blvd Yorktown IN 47396-9250 | |
| (765) 759-4068 | |
| (765) 759-4075 |
| Full Name | Iu Health Ball Memorial Physicians |
|---|---|
| Speciality | Family Medicine |
| Location | 1420 S Pilgrim Blvd, Yorktown, Indiana |
| Authorized Official Name and Position | Janet L Vangets (DIRECTOR/OFFICER) |
| Authorized Official Contact | 7657513311 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Iu Health Ball Memorial Physicians 250 N Shadeland Ave Attn: Carol Boyd Indianapolis IN 46219-4959 Ph: (317) 963-0413 | Iu Health Ball Memorial Physicians 1420 S Pilgrim Blvd Yorktown IN 47396-9250 Ph: (765) 759-4068 |
| NPI Number | 1710206990 |
|---|---|
| Provider Enumeration Date | 05/27/2010 |
| Last Update Date | 10/14/2013 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710206990 | NPI | - | NPPES |
| 200986050 C | Medicaid | IN | |
| DQ6230 | Other | IN | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
News Archive
Starting this week, the new regulations for the containment of the coronavirus adopted by the Federal Government and the Länder will come into force throughout Germany.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
In a major crackdown, Cambodia has forced nearly 65 percent of illegal pharmacies operating in the country to close within the past five months. Led by an Inter-Ministerial Committee to Fight against Counterfeit & Substandard Medicines (IMC), the shops were targeted because of evidence that they were among the primary sources of substandard and counterfeit medicines in the country.
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.
› Verified 5 days ago
Quad/med, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2005 S Tiger Dr, Yorktown, IN 47396 Phone: 888-417-1001 | |
Chs Health And Diagnostic Center Of Yorktown Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1420 S Pilgrim Blvd, Yorktown, IN 47396 Phone: 765-759-4068 Fax: 765-759-4075 |